I am not sure that the COVID-19 track will bring anything meaningful - I could well be wrong but there seems to be no pointers to success in this area.
Nothing will replace a vaccine - and BIT is not chasing that - more of something to alleviate symptoms. MERCK is basically developing a cold and flu medication - with the benefits of clearing air ways and an inflammatory plus a pain suppressor.
Given that simple solution then we have to ask what BIT is doing in the field.
I still say that HIV/HepC is BITs forte and they should concentrate their efforts in that area. Having unrealistic expectations that BIT will have a huge breakthrough with OID-19 may just bring about disappointment.
Know I am not being very optimistic with COV-19 and will upset some here - sorry about that.
Have Merck beaten us to the punch?, page-41
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $54.13M | |||
| Open | High | Low | Value | Volume |
| 6.3¢ | 6.3¢ | 6.0¢ | $37.36K | 608.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 49999 | 6.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.1¢ | 49855 | 2 |
View Market Depth
| Last trade - 16.10pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.1¢ |
Change
0.000 ( 1.67 %) |
||||
| Open | High | Low | Volume | ||
| 6.3¢ | 6.3¢ | 6.0¢ | 350766 | ||
| Last updated 13.05pm 08/05/2024 ? | |||||
| BIT (ASX) Chart |